FirstSun (FSUN) Q1 2026 Earnings Call Transcript

FirstSun Capital Bancorp reported adjusted net income of $23.7 million, adjusted EPS of $0.84, and a 4.25% net interest margin, while loan balances grew 16% annualized and noninterest income rose about 25% year over year. Management said First Foundation integration is ahead of schedule, with $1.0 billion of the planned $2.3 billion loan downsizing completed, wholesale funding targeted to 10% by Q2-end, and CET1 expected around 11% post-repositioning. Guidance calls for full-year NIM in the mid-3.80s, efficiency in the mid- to low-60s near term, and net charge-offs in the mid-20 bps range.

Analysis

FSUN is in the awkward but ultimately favorable phase of an integration where reported earnings quality should improve before headline growth does. The key second-order effect is that the acquired balance sheet is being intentionally shrunk and de-risked, which suppresses near-term loan balance expansion but creates a cleaner, more predictable earnings base with better capital flexibility later in 2026 and into 2027. That matters because banks often get rewarded less for raw growth than for visible conversion of purchased assets into sticky deposits and fee-bearing relationships; if management executes, the market can re-rate the franchise on durability rather than on a one-quarter ROA print.

The more important signal is that credit is being normalized through pruning, not through benign macro conditions. A heavy C&I mix means charge-offs will remain episodic, but management is effectively telling us that the quarter’s losses were idiosyncratic and that future provision volatility should compress as legacy problem pockets are reset inside purchase accounting. The risk is that investors underwrite the mid-20s bps guidance as a steady-state outcome when it may actually be a transitional number; if growth reaccelerates before relationship deposits replace wholesale balances, funding costs and credit noise could both spike together.

For relative value, the stock looks more interesting as a post-event deleveraging story than as a pure earnings momentum name. The combination of ~11% CET1, explicit buyback capacity, and a path to lower efficiency after system conversions creates a catalyst stack over the next 2-3 quarters, while the near-term margin trough offers a cleaner setup for investors willing to look through Q2/Q3 noise. The contrarian point is that the market may be over-discounting dilution from the deal while underappreciating how much optionality comes from converting purchased wholesale-funded balances into core deposits in high-growth geographies.

The key watch item is not the reported NIM trough; it is whether deposit remix actually accelerates enough to offset the planned runoff in multifamily and brokered funding by late summer. If core deposit growth stalls, the equity should de-rate quickly because the whole bull case depends on replacing purchased funding with low-cost operating balances before the conversion-related cost savings fully show up. If that happens, the stock becomes a much better 6-12 month long than an immediate momentum buy.

Key Decisions for Investors

• Long FSUN common into Q2/Q3 weakness, with a 6-9 month horizon: the setup is asymmetric if the market discounts the planned NIM dip before recognizing buyback capacity and synergy capture; use pullbacks toward post-earnings support as entry.
• Pair trade: long FSUN / short a slower-growing regional bank with similar valuation but weaker capital flexibility and no M&A synergies; this isolates the cleaner post-integration catalyst versus a generic rate-beta trade.
• If liquid options are available, buy 3-6 month FSUN call spreads rather than outright calls: the main risk is timing slippage on deposit remix and system conversion, so defined-risk upside exposure is preferable to linear delta.
• Avoid FFWM as a standalone thesis vehicle; the value creation is now in the acquirer’s execution and capital release, not in trying to handicap the acquired asset base independently.
• Set a hard stop if wholesale funding or deposit remix trends worsen over the next two quarters: that would invalidate the post-repositioning funding-cost thesis and likely cap the stock well before synergy benefits show up.